维普期刊资源整合服务平台（V6.5）

116篇 您的检索式：作者名="Jakesz"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer显示文摘	Klaus Sahora Irene Kuehrer Axel Eisenhut Belgin Akan Claus Koellblinger Peter Goetzinger Bela Teleky Raimund Jakesz Markus Peck-Radosavljevic Ahmed Ba’ssalamah Christoph Zielinski Michael Gnant	2011	Surgery2011，，3：	2
2	Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide,methotrexate,and fluorouracil:evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer-Austrian Breast and Colorectal Cancer Study Group Trial 5显示文摘	Jakesz R Hausmaninger H Kubista E	2002	J Clin Oncol2002，20，24：	1
3	Contralateral Breast Cancer: Molecular Differentiation Between Metastasis and Second Primary Cancer显示文摘	Elisabeth Janschek Daniela Kandioler-Eckersberger Carmen Ludwig Sonja Kappel Brigitte Wolf Susanne Taucher Margaretha Rudas Michael Gnant Raimund Jakesz	2001	Breast Cancer Research and Treatment2001，，1：	1
4	Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years 'adjuvam tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial 显示文摘	Jakesz R Jonat W Gnant M	2005	Lancet2005，366，：	1
5	The future of breast cancer management显示文摘	Harbeek N Jakesz R Thomssen C	2008	Breast Care (Basel)2008，3，6：	1
6	Anemia is a significant prognostic factor in local relapse-free survival of premeno-pausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemo-therapy显示文摘	Dubsky P Sevelda P Jakesz R		0，，07：	1
7	Influence of Neoadjuvant Therapy with Epirubicin and Docetaxel on the Expression of HER2/neu in Patients with Breast Cancer显示文摘	Susanne Taucher Margaretha Rudas Robert M. Mader Michael Gnant Emanuel Sporn Peter Dubsky Sebastian Roka Thomas Bachleitner Florian Fitzal Daniela Kandioler Catharina Wenzel Günther G. Steger Martina Mittlb?ck Raimund Jakesz	2003	Breast Cancer Research and Treatment2003，，3：	1
8	Breast cancer issues in developing countries:an overview of the breast health global initiative 显示文摘	Anderson B O Jakesz R	2008	World J Surg2008，32，12：	1
9	Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells显示文摘	Jakesz R Smith CA Aitken S	1984	Cancer Res1984，44，2：	1
10	Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group 显示文摘	Jakesz R Samonigg H Gnant M	2003	Ann Surg2003，237，4：	1
11	Anemia is a significant prognos-tic factor in local relapse-free survival of premenopausal primarybreast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy显示文摘	Dubsky P Sevelda P Jakesz R	2008	Clin Cancer Res2008，14，7：	1
12	A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors 显示文摘	Filipits M Rudas M Jakesz R	2011	Clin Cancer Res2011，17，18：	1
13	Switching of postmenopausal women with endocrine - responsive early breast cancer to anastrozole after 2 years adjuvant tamoxifen : combined results of ABCSG Trial 8 and ARNO 95 Trial显示文摘	Jakesz R Jonat W Gnant M	2005	Lancet2005，366，9484：	1
14	The potential risk of neoadjuvant chemotherapy in breast cancer patients- -results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07) 显示文摘	Taucher S Steger GG Jakesz R	2008	Breast Cancer Res Treat2008，112，2：	1
15	Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial显示文摘	Michael Gnant Brigitte Mlineritsch Herbert Stoeger Gero Luschin-Ebengreuth Dietmar Heck Christian Menzel Raimund Jakesz Michael Seifert Michael Hubalek Gunda Pristauz Thomas Bauernhofer Holger Eidtmann Wolfgang Eiermann Guenther Steger Werner Kwasny Peter	2011	Lancet Oncology2011，，7：	1
16	Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group显示文摘	Jakesz R Samonigg H Gnant M	2003	Ann Surg2003，237，4：	1
17	Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil : evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone - responsive breast cancer Austrian Breast and Colorectal Cancer Study Group Trial 5 显示文摘	Jakesz R Hausmaninger H Kubista E	2002	J Clin Oncol2002，20，24：	1
18	Randomized adjuvant trial of tamo-xifen and goserelin versus cyclophosphamide,methotrexate,and fluorou-racil:evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer-Austrian Breast and Colorectal Cancer Study Group Trial 5显示文摘	Jakesz R Hausmaninger H Kubista E	2002	J Clin oncol2002，20，24：	1
19	Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial显示文摘	Jakesz R Jonat W Gnant M	2005	Lancet2005，366，9484：	1
20	Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen : combined results of the ABCSG trial 8 and ARNO 95 trial 显示文摘	Jakesz R Jonat W Gnant M	2005	Lancet2005，366，9484：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示